PHASE-II TRIALS OF THE SEROTONIN ANTAGONIST GR38032F FOR THE CONTROL OF VOMITING CAUSED BY CISPLATIN

被引：110

作者：

KRIS, MG ^{[1
]}

GRALLA, RJ ^{[1
]}

CLARK, RA ^{[1
]}

TYSON, LB ^{[1
]}

机构：

[1] CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 01期

关键词：

D O I：

10.1093/jnci/81.1.42

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：42 / 46

页数：5

共 18 条

[1] BINOMIAL CONFIDENCE-INTERVALS [J].

BLYTH, CR ;

STILL, HA .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1983, 78 (381) :108-116

[2] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].

BRADLEY, PB ;

ENGEL, G ;

FENIUK, W ;

FOZARD, JR ;

HUMPHREY, PPA ;

MIDDLEMISS, DN ;

MYLECHARANE, EJ ;

RICHARDSON, BP ;

SAXENA, PR .

NEUROPHARMACOLOGY, 1986, 25 (06) :563-576

[3]

BRITTAIN R T, 1987, British Journal of Pharmacology, V90, p87P

[4]

CLARK R, 1985, ONCOL NURS FORUM S, V12, P96

[5]

COSTALL B, 1987, British Journal of Pharmacology, V90, p90P

[6] PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST [J].

CUNNINGHAM, D ;

POPLE, A ;

FORD, HT ;

HAWTHORN, J ;

GAZET, JC ;

CHALLONER, T ;

COOMBES, RC .

LANCET, 1987, 1 (8548) :1461-1463

[7] NABILONE - AN EFFECTIVE ANTI-EMETIC AGENT IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].

EINHORN, L .

CANCER TREATMENT REVIEWS, 1982, 9 :55-61

[8]

GRALLA RJ, 1984, CANCER TREAT REP, V68, P163

[9] ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].

GRALLA, RJ ;

ITRI, LM ;

PISKO, SE ;

SQUILLANTE, AE ;

KELSEN, DP ;

BRAUN, DW ;

BORDIN, LA ;

BRAUN, TJ ;

YOUNG, CW .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909

[10]

GRUNBERG SM, 1988, P ASCO, V7, P279

← 1 2 →